Imperial College London
Portrait Picture

Dr John S Tregoning

Faculty of Medicine, Department of Infectious Disease

Professor in Vaccine Immunology
 
 
 
//

Contact

 

john.tregoning Website

 
 
//

Location

 

456 (Shattock Group)Wright Fleming WingSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@inbook{Tregoning:2014:10.1128/microbiolspec.PLAS-0028-2014,
author = {Tregoning, JS and Kinnear, E},
booktitle = {Plasmids: Biology and Impact in Biotechnology and Discovery},
doi = {10.1128/microbiolspec.PLAS-0028-2014},
publisher = {ASMscience},
title = {Using Plasmids as DNA Vaccines for Infectious Diseases.},
url = {http://dx.doi.org/10.1128/microbiolspec.PLAS-0028-2014},
year = {2014}
}
Download

RIS format (EndNote, RefMan)

TY  - CHAP
AB  - DNA plasmids can be used to induce a protective (or therapeutic) immune response by delivering genes encoding vaccine antigens. That naked DNA (without the refinement of coat proteins or host evasion systems) can cross from outside the cell into the nucleus and be expressed is particularly remarkable given the sophistication of the immune system in preventing infection by pathogens. As a result of the ease, low cost, and speed of custom gene synthesis, DNA vaccines dangle a tantalizing prospect of the next wave of vaccine technology, promising individual designer vaccines for cancer or mass vaccines with a rapid response time to emerging pandemics. There is considerable enthusiasm for the use of DNA vaccination as an approach, but this enthusiasm should be tempered by the successive failures in clinical trials to induce a potent immune response. The technology is evolving with the development of improved delivery systems that increase expression levels, particularly electroporation and the incorporation of genetically encoded adjuvants. This review will introduce some key concepts in the use of DNA plasmids as vaccines, including how the DNA enters the cell and is expressed, how it induces an immune response, and a summary of clinical trials with DNA vaccines. The review also explores the advances being made in vector design, delivery, formulation, and adjuvants to try to realize the promise of this technology for new vaccines. If the immunogenicity and expression barriers can be cracked, then DNA vaccines may offer a step change in mass vaccination.
AU  - Tregoning,JS
AU  - Kinnear,E
DO  - 10.1128/microbiolspec.PLAS-0028-2014
PB  - ASMscience
PY  - 2014///
SN  - 9781555818975
TI  - Using Plasmids as DNA Vaccines for Infectious Diseases.
T1  - Plasmids: Biology and Impact in Biotechnology and Discovery
UR  - http://dx.doi.org/10.1128/microbiolspec.PLAS-0028-2014
ER  -
Download